Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Migraine prevention.

D W Dodick1, S D Silberstein

  • 1Department of Neurology, Mayo Clinic Arizona, Scottsdale, Arizona 85259, USA. Dodick.David@mayo.edu

Practical Neurology
|November 21, 2007
PubMed
Summary
This summary is machine-generated.

Preventive migraine medications lower headache frequency and improve quality of life. They also enhance acute treatment response and may prevent chronic daily headache, though many eligible patients do not receive them.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Single-item migraine screening tests, self-reported bothersome headache or stripe pattern hypersensitivity?

Acta neurologica Scandinavica·2015
Same author

Pooled analysis of the safety and tolerability of onabotulinumtoxinA in the treatment of chronic migraine.

European journal of neurology·2014
Same author

Headache in the elderly.

Journal of back and musculoskeletal rehabilitation·2014
Same author

OnabotulinumtoxinA for chronic migraine: efficacy, safety, and tolerability in patients who received all five treatment cycles in the PREEMPT clinical program.

Acta neurologica Scandinavica·2013
Same author

Efficacy endpoints in migraine clinical trials: the importance of assessing freedom from pain.

Current medical research and opinion·2013
Same author

Emerging target-based paradigms to prevent and treat migraine.

Clinical pharmacology and therapeutics·2012
Same journal

Who I am affects what I do.

Practical neurology·2026
Same journal

Recurrent falls while taking clozapine.

Practical neurology·2026
Same journal

Anti-Ma2 encephalitis: when the examination localises beyond MRI.

Practical neurology·2026
Same journal

Oculopharyngeal muscular dystrophy: diagnosis, management and multisystem care.

Practical neurology·2026
Same journal

Neurological signs of possible diagnostic value in the cognitive clinic: past, present and future.

Practical neurology·2026
Same journal

Longitudinally extensive myelitis in neurosarcoidosis.

Practical neurology·2026
See all related articles

Area of Science:

  • Neurology
  • Pharmacology

Background:

  • Migraine is a common neurological disorder impacting quality of life.
  • Preventive medications are crucial for managing migraine frequency and severity.

Observation:

  • Many patients who could benefit from preventive migraine treatment are not offered or do not receive it.
  • Successful management requires aligned patient-physician expectations and individualized treatment strategies.

Findings:

  • Preventive therapies reduce migraine frequency, severity, and improve quality of life.
  • These medications can enhance acute treatment efficacy and potentially prevent progression to chronic daily headache.
  • Rational combinations of preventive drugs may offer additional benefits.

Implications:

Related Experiment Videos

  • Optimizing the use of preventive migraine medications is essential for improving patient outcomes.
  • Individualized treatment selection, realistic expectations, and careful titration are key to successful migraine management.
  • Further research into rational drug combinations could enhance therapeutic strategies.